Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate the Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy

NCT05933057 is registered in ClinicalTrials.gov with Italfarmaco as lead sponsor.

NCT NCT05933057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05933057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate the Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Lead sponsor
Italfarmaco
Phase
Phase 3
Overall status
Recruiting
Start date
February 19, 2024
Completion date
February 29, 2028
Enrollment
138 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy